583 related articles for article (PubMed ID: 9275684)
41. [Current topics in the diagnosis and treatment of malignant fibrous histiocytoma].
Chuman H
Gan To Kagaku Ryoho; 2003 May; 30(5):626-33. PubMed ID: 12795093
[TBL] [Abstract][Full Text] [Related]
42. Intraoperative radiotherapy for primary and locally recurrent soft tissue sarcoma: morbidity and long-term prognosis.
Lehnert T; Schwarzbach M; Willeke F; Treiber M; Hinz U; Wannenmacher MM; Herfarth C
Eur J Surg Oncol; 2000 Nov; 26 Suppl A():S21-4. PubMed ID: 11130875
[TBL] [Abstract][Full Text] [Related]
43. [Multidisciplinary treatment of bone and soft tissue sarcomas].
Furuya K; Wada N; Kawaguchi N; Amino K
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1063-72. PubMed ID: 4057570
[TBL] [Abstract][Full Text] [Related]
44. Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft tissue sarcoma.
Tsuchiya H; Yamamoto N; Asada N; Terasaki T; Kanazawa Y; Takanaka T; Nishijima H; Tomita K
Anticancer Res; 2000; 20(3B):2137-43. PubMed ID: 10928167
[TBL] [Abstract][Full Text] [Related]
45. Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma.
Menendez LR; Ahlmann ER; Savage K; Cluck M; Fedenko AN
Clin Orthop Relat Res; 2007 Feb; 455():219-24. PubMed ID: 17016226
[TBL] [Abstract][Full Text] [Related]
46. Optimizing local control in soft tissue sarcoma of the extremity.
Gwin JL; Bell JL
Oncology (Williston Park); 1994 Jul; 8(7):25-31; discussion 32, 37-8, 41. PubMed ID: 7917837
[TBL] [Abstract][Full Text] [Related]
47. Epithelioid sarcoma: the University of Washington experience.
Wolf PS; Flum DR; Tanas MR; Rubin BP; Mann GN
Am J Surg; 2008 Sep; 196(3):407-12. PubMed ID: 18436180
[TBL] [Abstract][Full Text] [Related]
48. Limb-sparing treatment for soft tissue sarcomas: influence of prognostic factors.
Rossi CR; Foletto M; Alessio S; Menin N; D'Amore E; Rigon A; Lise M
J Surg Oncol; 1996 Sep; 63(1):3-8. PubMed ID: 8841460
[TBL] [Abstract][Full Text] [Related]
49. Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.
Smith KB; Indelicato DJ; Knapik JA; Lagmay JP; Morris C; Kirwan JM; Zlotecki RA; Scarborough MT; Gibbs CP; Marcus RB
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):150-7. PubMed ID: 21550181
[TBL] [Abstract][Full Text] [Related]
50. The prognostic significance of margin width for extremity and trunk sarcoma.
McKee MD; Liu DF; Brooks JJ; Gibbs JF; Driscoll DL; Kraybill WG
J Surg Oncol; 2004 Feb; 85(2):68-76. PubMed ID: 14755506
[TBL] [Abstract][Full Text] [Related]
51. Prognostic factors in localized soft-tissue sarcomas.
Kaytan E; Yaman F; Cosar R; Eralp Y; Saip P; Darendeliler E
Am J Clin Oncol; 2003 Aug; 26(4):411-5. PubMed ID: 12902897
[TBL] [Abstract][Full Text] [Related]
52. Inadvertent tumor violation during musculoskeletal sarcoma surgery and risk of recurrence.
Ogihara Y; Sudo A; Fujinami S
Jpn J Clin Oncol; 1992 Aug; 22(4):264-9. PubMed ID: 1331572
[TBL] [Abstract][Full Text] [Related]
53. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma.
Pawlik TM; Pisters PW; Mikula L; Feig BW; Hunt KK; Cormier JN; Ballo MT; Catton CN; Jones JJ; O'Sullivan B; Pollock RE; Swallow CJ
Ann Surg Oncol; 2006 Apr; 13(4):508-17. PubMed ID: 16491338
[TBL] [Abstract][Full Text] [Related]
54. [The effects of surgical margins on local control and survival in extremity soft tissue sarcomas].
Yildiz C; Erler K; Bilgiç S; Ateşalp AS; Başbozkurt M
Acta Orthop Traumatol Turc; 2003; 37(5):359-67. PubMed ID: 14963391
[TBL] [Abstract][Full Text] [Related]
55. Head and neck soft tissue sarcomas: a multivariate analysis of outcomes.
Bentz BG; Singh B; Woodruff J; Brennan M; Shah JP; Kraus D
Ann Surg Oncol; 2004 Jun; 11(6):619-28. PubMed ID: 15172935
[TBL] [Abstract][Full Text] [Related]
56. Surgical management of soft tissue sarcomas of the hand and foot.
Lin PP; Guzel VB; Pisters PW; Zagars GK; Weber KL; Feig BW; Pollock RE; Yasko AW
Cancer; 2002 Aug; 95(4):852-61. PubMed ID: 12209730
[TBL] [Abstract][Full Text] [Related]
57. Chemotherapy of soft tissue sarcomas in the extremities.
Sudo A; Fujinami S; Shiokawa Y; Ogihara Y
Jpn J Clin Oncol; 1991 Oct; 21(5):346-52. PubMed ID: 1753415
[TBL] [Abstract][Full Text] [Related]
58. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
[TBL] [Abstract][Full Text] [Related]
59. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival.
Gronchi A; Lo Vullo S; Colombo C; Collini P; Stacchiotti S; Mariani L; Fiore M; Casali PG
Ann Surg; 2010 Mar; 251(3):506-11. PubMed ID: 20130465
[TBL] [Abstract][Full Text] [Related]
60. [Retrospective analysis and prognostic factors of 208 cases of primary soft tissue sarcoma of extremity].
Li Y; Niu XH; Xu HR
Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):964-9. PubMed ID: 22333413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
